Washington D.C. – Democrats in Congress are intensifying pressure on Veterans Affairs Secretary Doug Collins to permanently halt a recently paused policy that could lead to reduced medical benefits for millions of veterans. The policy, which directed medical examiners to evaluate disability ratings based on a veteran’s response to medication rather than the severity of the underlying condition, sparked immediate backlash from veteran advocacy groups and raised concerns about potential cost-cutting measures at the expense of those who served.
The core of the dispute centers on how the VA assesses the impact of service-connected disabilities. The paused guidance, issued February 17th, instructed examiners to focus on a veteran’s level of impairment whereas undergoing treatment, potentially diminishing benefits for those whose symptoms are managed, but not fully cured. This shift in evaluation criteria prompted fears that veterans relying on medication to manage chronic conditions could see their disability ratings – and corresponding financial support – lowered. The issue of Doug Collins’s leadership at the VA is now under increased scrutiny.
A letter signed by 21 Democrats and Independents on the House and Senate Veterans’ Affairs committees demands a formal confirmation by Monday that the rule is “dead,” along with a detailed timeline for its complete withdrawal and a justification for bypassing standard rule-making procedures. Sen. Richard Blumenthal of Connecticut, and Rep. Mark Takano of California, the ranking Democrats on their respective committees, are among the signatories. The VA did not respond to requests for comment, according to reports.
The controversy stems, in part, from a 2025 federal court ruling in Ingram v. Collins, where the court determined VA examiners should disregard the stabilizing effects of medication when evaluating a veteran’s condition. The Department of Veterans Affairs reportedly disagreed with the ruling, arguing it would expand eligibility and increase costs. The VA spent approximately $195 billion on disability programs last year.
Concerns Over Impact on Veteran Healthcare
Veteran advocacy groups have voiced strong opposition to the policy, arguing it could undermine access to essential healthcare. They contend that evaluating disability based on symptom management overlooks the ongoing challenges faced by veterans with chronic conditions. Conditions like traumatic brain injuries and mental health disorders often present inconsistently, making a single “snapshot” evaluation unreliable and potentially detrimental to a veteran’s long-term care.
The VA’s nearly 7 million disabled patients already undergo regular reviews of their disability ratings. While the exact number of veterans who would be affected by the regulation remains unclear, approximately 5 million veterans receive prescriptions through the VA, according to 2019 data. A reduction in benefits could have far-reaching consequences, impacting access to healthcare, property tax relief, and other vital support services.
